Search results
Results From The WOW.Com Content Network
It now expects earnings per share between $2.15 and $2.35. That's up from previous guidance of between $2.05 and $2.25. The company's dividend is $0.42 per share quarterly, or $1.68 annually. It's ...
Here's how Pfizer just confirmed it's a dividend investor's dream stock. 1. A juicy dividend that management supports. Anyone who has followed Pfizer lately knows it offers a high forward dividend ...
Shares of Pfizer offer an eye-popping 6.1% dividend yield at recent prices. Is the stock a buy for income-seeking investors? To find out, we'll need to weigh its strengths against reasons to avoid ...
S&P 500 Dividend Aristocrats. The S&P 500 Dividend Aristocrats is a stock market index composed of the companies in the S&P 500 index that have increased their dividends in each of the past 25 consecutive years. It was launched in May 2005.
Pfizer's slightly higher dividend yield and broad pipeline give it the edge in this comparison. That said, BMS stock should perform admirably for investors with a long-term horizon.
Pfizer Inc. ( / ˈfaɪzər / FY-zər) [3] is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).
Pfizer stock's starting dividend yield is currently 5.5%, higher than Abbott Labs and Johnson & Johnson. The dividend equates to roughly 65% of Pfizer's estimated 2024 earnings, so management ...
PFE Dividend Yield data by YCharts. The takeaway on Pfizer's stock. The takeaway from the second-quarter earnings report is that the company is finally turning the page on its volatile later ...